cagrilintide and tirzepatide together Lilly’s New Add On! (Not Eloralintide) Cagrilintide + Tirzepatide Peptide Stack

This report is an extension of our poster presented at AMCP, titled Impact of the CVS GLP-1 formulary change

Ingredients include L-Carnitine Tartrate, microcrystalline cellulose, bamboo extract, and L-Leucine, formulated to aid athletes' physical condition

Initial combination therapy or maintenance of combination therapy should be individualized and left to the discretion of the health care provider

Integrating genetic predisposition data with biomarker assessment (B12 status, homocysteine, liver function, carnitine) and your clinical history enables a more informed conversation with your provider about whether MIC B12, oral supplements, GLP-1 peptide therapy, or multimodal metabolic support is most appropriate for your individual situation

Nausea is most common in the first few days following an injection and typically improves as your body adjusts to the medication

The formulation is compounded by our 503A pharmacy to meet individual patient needs as determined by the prescribing provider